PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes. (Q48297683)

From Wikidata

Jump to navigation Jump to search

scientific article

PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes

Language	Label	Description	Also known as
English	PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes.	scientific article	PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

based on heuristic

inferred from title

Moufida Ben Nasr

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Francesca D'Addio

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Silvana Belletti

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Gian Paolo Fadini

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Christian Schuetz

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

Chiara Mameli

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Vera Usuelli

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Anna Maestroni

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Domenico Corradi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Gabriella Becchi

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

James Markmann

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Clive Wasserfall

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Gian Vincenzo Zuccotti

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

language of work or name

0 references

publication date

1 November 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Science Translational Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

416

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Genetics, pathogenesis and clinical interventions in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Targeting CD22 reprograms B-cells and reverses autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

The rise, fall, and resurgence of immunotherapy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

The hematopoietic stem cell landscape

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Factors impeding the discovery of an intervention-based treatment for type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Human islets express a marked proinflammatory molecular signature prior to transplantation.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Autologous umbilical cord blood transfusion in very young children with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Immunological applications of stem cells in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic Enteropathy

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAM7543

21 January 2018

Mechanisms of PDL1-mediated regulation of autoimmune diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/29141886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/29141886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1126/SCITRANSLMED.AAM7543

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

2017Sci.....9.....B

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29141886%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48297683&oldid=1551661118"